SKYEPHARMA
DEAD

Serial Number

87730607

Owner

JAGOTEC AG

Attorney

Roberta S. Bren

Filing Date

Dec 21, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SKYEPHARMA Trademark

Serial Number: 87730607 • Registration: 5742573

SKYEPHARMA is a trademark filed by JAGOTEC AG on December 21, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

JAGOTEC AG (32 trademarks)

POSTFACH 244
HERGISWIL NW , CH

Entity Type: 03

Trademark Details

Filing Date

December 21, 2017

Registration Date

May 7, 2019

Published for Opposition

November 20, 2018

Cancellation Date

November 21, 2025

Goods & Services

Transdermal patches sold without medication for use in the timed delivery of drugs; Surgical, medical, and veterinary apparatus and instruments, namely, surgical scrub suits, masks and gowns, surgical cutlery, medical tubing for irrigation and drainage purposes, wound drainage apparatus; wound mending devices, namely, surgical clips; surgical implants comprising artificial material; inhalers for therapeutic use; medical syringes; needles for medical use; devices for the injection of medicines, namely, hypodermic needles, hypodermic and medical syringes and catheters; apparatus, instruments and devices for storing and dispensing medical, surgical and veterinary preparations, creams, powders, tablets and pills, namely, pharmaceutical containers especially made for storing and dispensing creams, powders, tablets, pills, medical waste, urine and blood, cups for dispensing medicine and medical infusion pumps for dispensing medicines for use in the delivery and control of medical nutritional fluids; containers especially adapted for storing surgical devices, namely, for storing spoons, syringes, suppositories, vials, intravenous sets, inhalers, sprays, and adhesive and medical tapes; replacement parts and fittings for all of the aforesaid

Chemical additives for use in the manufacture of therapeutic pharmaceuticals, chemical reagents for scientific or medical research use; and chemicals and bio chemicals, namely, enzymes for use in biochemical research and in the diagnostic, agriculture and forestry industries; diagnostic preparations for clinical or medical laboratory use

Medical research and development in the fields of pharmaceutical delivery methods and the development of new pharmaceuticals; research and development of new surgical products for others; veterinary research and development; scientific research and development; new product design services for others; product development; engineering design services for others

[ Dietary supplements for medical and veterinary purposes; ] medical and veterinary plasters, adhesive tapes and adhesive bandages; wound dressings; transdermal patches for use in the timed delivery of drugs, namely, transdermal patches for use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genito-urinary system, renal system, gastro-intestinal system, liver disorders, immune system, musculo-skeletal and inflammatory disorders, neuromuscular disorders, tuberculosis, and for use in oncology and haematology; surgical dressings and burn dressings; analgesics; bacterial preparations for medical and veterinary purposes for use as anti-infectives; chemical preparations and reagents for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genito-urinary system, renal system, gastro-intestinal system, liver disorders, immune system, musculo-skeletal and inflammatory disorders, neuromuscular disorders, tuberculosis, and for use in oncology and haematology; [ food for medically restricted diets, namely, vitamin-fortified beverages for medical and veterinary uses; nutritionally fortified beverages for medical and veterinary uses; ] pharmaceutical preparations for post-cosmetic surgery for use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genito-urinary system, renal system, gastro-intestinal system, liver disorders, immune system, musculo-skeletal and inflammatory disorders, neuromuscular disorders, tuberculosis, and for use in oncology and haematology; [ dietary food supplements for medically restricted diets, and diet pills, all for medical and veterinary purposes; ] topical gels, ointments, creams and powder for relief of itching and irritated skin for medical and veterinary purposes; suppositories and unit dose capsules sold empty for pharmaceutical medical and veterinary use; pharmaceuticals having a time release effect for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genito-urinary system, renal system, gastro-intestinal system, liver disorders, immune system, musculo-skeletal and inflammatory disorders, neuromuscular disorders, tuberculosis, and for use in oncology and haematology; anti-inflammatory and anti-bacterial pharmaceuticals for post cosmetic procedure treatments; and surgical implants comprising living tissue; bandages for skin wounds

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 21, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 7, 2024 REM1
TTAB RELEASE CASE TO TRADEMARKS
Jan 3, 2022 TMBN
CANCELLATION TERMINATED NO. 999999
Jan 3, 2022 CANT
AMENDMENT UNDER SECTION 7 - PROCESSED
Dec 24, 2021 A7OK
CANCELLATION DENIED NO. 999999
Dec 20, 2021 CAND
CANCELLATION INSTITUTED NO. 999999
Nov 30, 2021 PETC
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 2, 2019 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 2, 2019 AITU
NOTICE OF ALLOWANCE CANCELLED
Mar 15, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Mar 15, 2019 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 15, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 31, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 10, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 10, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 10, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 10, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 5, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 10, 2018 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2018 NWOS
NEW APPLICATION ENTERED
Dec 25, 2017 NWAP